yellow fever vaccine market growth, yellow fever vaccine market statistics, yellow fever vaccine market size, yellow fever vaccine market forecast, yellow fever vaccine market, yellow fever vaccine market research
How large is the yellow fever vaccine market, and what is its growth trajectory?
The yellow fever vaccine market size has grown strongly in recent years. It will grow from $4.54 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to the initiation of global immunization campaigns, implementation of international health regulations, mass vaccination campaigns, and advances in vaccine production technology.
The yellow fever vaccine market size is expected to see strong growth in the next few years. It will grow to $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increased collaboration and partnerships, integration with routine vaccination schedules, surveillance and monitoring, increasing involvement of the private sector, and adoption of digital technologies for vaccine tracking. Major trends in the forecast period include diversification of vaccine formats, pandemic preparedness, regulatory changes, healthcare infrastructure improvements, consumer education and awareness.
Get Your Free Sample of The Global Yellow Fever Vaccine Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp
What are the key forces behind the yellow fever vaccine market’s growth in recent years?
Increasing international travel is expected to propel the growth of the yellow fever vaccine market going forward. International travel refers to the movement of individuals across country borders for purposes such as tourism, business, or personal reasons. International travel is rising due to increased global connectivity, economic growth, and the relaxation of travel restrictions post-pandemic. The yellow fever vaccine is required or recommended for travelers visiting regions where yellow fever is endemic to prevent infection and comply with international health regulations. For instance, in January 2024, according to the World Tourism Organization, a Spain-based agency, in 2023, there were 1.286 billion international tourists (overnight visitors) globally, while in 2022, there were 960 million international tourists (overnight visitors). This shows an increase of 326 million international tourists from 2022 to 2023. Therefore, increasing international travel is driving the growth of the yellow fever vaccine market.
What are the major segments of the yellow fever vaccine market?
The yellow fever vaccine market covered in this report is segmented –
1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users
Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report
Which companies dominate the yellow fever vaccine market?
Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.
What major trends will shape the yellow fever vaccine market during the forecast period?
Major companies operating in the yellow fever vaccine market are focusing on developing effective next-generation yellow fever vaccines, such as the T-cell adaptive booster vaccine, to meet an increasing global vaccine demand. A T-cell adaptive booster vaccine is a type of vaccine designed to enhance the immune system’s memory T-cell response, providing prolonged and robust immunity against specific pathogens. For instance, in April 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, partnered with ATCC, a US-based non-profit organization that provides reference microorganisms, cell lines, and other materials for research and development, to introduce CD8+ T-cell adaptive vaccines. These vaccines are specifically designed for yellow fever and aim to stimulate a potent cytotoxic T-cell response, which is essential for identifying and eliminating virus-infected cells. By promoting the production of memory CD8+ T-cells, these vaccines provide long-lasting and robust immunity. They focus on the cellular immune response rather than just antibody production, thus offering comprehensive protection against yellow fever and potentially enhancing effectiveness in individuals with different immune profiles.
What are the key regional dynamics of the yellow fever vaccine market, and which region leads in market share?
North America was the largest region in the yellow fever vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Yellow Fever Vaccine Market Report 2025 Offer?
The yellow fever vaccine market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
The yellow fever vaccine is a live, attenuated viral vaccine used to prevent yellow fever, a serious viral infection transmitted by mosquitoes. It is typically administered as a single dose and provides long-lasting immunity, often lifelong. The vaccine is especially important for people living in or traveling to endemic areas.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17297
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
